CDKN2A and familial pancreatic carcinoma: In a recent study, 77 patients with the p16-Leiden germline mutation were screened using MRI/MRCP, and 9% (7/77) had pancreatic cancer, while 11% (9/77) had cystic lesions that were not otherwise categorized [118].